Overview

Simvastatin as an Add-on Treatment to Interferon-beta-1a for the Treatment of Relapsing-Remitting Multiple Sclerosis

Status:
Completed
Trial end date:
2010-04-01
Target enrollment:
Participant gender:
Summary
This study is to find out if there is any benefit to adding Simvastatin to Interferon-beta-1a in patients with Multiple Sclerosis.
Phase:
Phase 4
Details
Lead Sponsor:
Biogen
Treatments:
Interferon beta-1a
Interferon-beta
Interferons
Simvastatin